Abstract:Although a number of studies have shown therapeutic effects of mesenchymal stem cells (MSCs) on type 1 diabetes or diabetic complications, clinical applications of MSCs for these diseases are still limited. One of the reasons is aging of MSCs due to older donor age and ex vivo culture of MSCs before usage, which results in attenuation of their anti-inflammatory/immunomodulatory functions, as well as their proliferation/differentiation potencies. We previously reported that adipose tissue-derived stromal cells (ADSCs), one type of MSCs used in multiple clinical trials, exhibit anti-inflammatory/immunomodulatory functions when they become quiescent in gels with a stiffness mimicking that of adipose tissue. We also showed that transplants containing quiescent ADSCs enhanced diabetic wound healing more than did those containing non-quiescent ADSCs. Here, we investigated the effect of inducing quiescence in aged ADSCs on themselves and their neighboring ADCSs. ADSCs at high passage exhibited a flattened shape and impaired DNA damage repair response, accompanied by attenuated proliferation and increased secretion of monocyte chemoattractant protein-1 (MCP-1). However, introducing quiescence into these aged ADSCs by embedding them in soft gels eliminated these phenotypes associated with aging. Furthermore, administration of conditioned medium derived from ADSCs rendered quiescent at high passage significantly improved age-associated impaired proliferation and biased differentiation (impaired osteogenic differentiation) of ADSCs at high passage. These results suggest that quiescence rejuvenates ADSCs, which in turn provide factors that contribute to rejuvenation of other ADSCs. Thus, introducing quiescence in ADSCs may contribute to overcoming challenges in ADSC-based cell therapies due to their aging. Disclosure M. Funaki: Board Member; Mechanogenic, Inc. Stock/Shareholder; Mechanogenic, Inc. A. Hata: None.

P57kip2 is a Master Regulator of Human Adipose Derived Stem Cell Quiescence and Senescence

P57 is a Master Regulator of Human Adipose Derived Stem Cell Quiescence and Senescence

Senescence of Human Skin-Derived Precursors Regulated by Akt-FOXO3-p27 KIP1 /p15 INK4b Signaling

Pim2 Regulates Stemness Through Phosphorylation of 4E-Bp1

Histone Arginine Methylation-Mediated Epigenetic Regulation of Discoidin Domain Receptor 2 Controls the Senescence of Human Bone Marrow Mesenchymal Stem Cells.

SIRT1 reverses senescence via enhancing autophagy and attenuates oxidative stress-induced apoptosis through promoting p53 degradation

p57 Suppresses the Pluripotency and Proliferation of Mouse Embryonic Stem Cells by Positively Regulating p53 Activation

CDK Inhibitor P57 (kip2) is Negatively Regulated by COP9 Signalosome Subunit 6.

The Rejuvenation and Functional Restoration of Aged Adipose Stem Cells by DUXAP10 Knockdown via the Regulation of the miR-214-3p/RASSF5 Axis

Cdk11 Safeguards The Identity Of Human Embryonic Stem Cells Via Fine-Tuning Signaling Pathways

KDM4 Orchestrates Epigenomic Remodeling of Senescent Cells and Potentiates the Senescence-Associated Secretory Phenotype

Quiescence and aging of melanocyte stem cells and a novel association with programmed death-ligand 1

The PI3K-Akt pathway inhibits senescence and promotes self-renewal of human skin-derived precursors in vitro

Declined Expression of Histone Deacetylase 6 Contributes to Periodontal Ligament Stem Cell Aging

p57Kip2 regulates embryonic haematopoietic stem cell numbers by controlling the size of the sympathoadrenal progenitor pool

The role of Skp2 in hematopoietic stem cell quiescence, pool size, and self-renewal

Photomodulation Alleviates the Senescence of Adipose-Derived Stem Cells Aging in Vitro

1492-P: Quiescent Adipose-Derived Mesenchymal Stromal Cells (ADSCs) Rejuvenate Themselves and Provide Factors That Remotely Restore Cellular Functions of Aged ADSCs

H2AK119ub dynamics controls hair follicle stem cell quiescence

Identifying specific functional roles for senescence across cell types

CRL2 APPBP2 -Mediated TSPYL2 Degradation Counteracts Human Mesenchymal Stem Cell Senescence